AUTHOR
Device-regulated; clinical use for venous insufficiency; athletic recovery use emerging and less regulated
13 Apr 2026
Unregulated training modality; emerging evidence for strength and hypertrophy at low loads
13 Apr 2026
The Long-Acting Phosphodiesterase-5 Inhibitor for Erectile Function and Hemodynamics
13 Apr 2026
The Original Phosphodiesterase-5 Inhibitor for Erectile Function
13 Apr 2026
The Metabolic Workhorse for Glucose Control and Longevity
13 Apr 2026
5-Alpha Reductase Inhibition for Prostate Health and Hair Preservation
13 Apr 2026
ARB with unique PPAR-gamma activation; off-label optimization use emerging
13 Apr 2026
Most prescribed drugs globally; approved for primary and secondary cardiovascular prevention
13 Apr 2026
Approved for type 2 diabetes, heart failure, and chronic kidney disease; off-label longevity and cardiometabolic optimization
13 Apr 2026
Wakefulness promotion with schedule IV controls
13 Apr 2026
FDA-approved OTC topical for hair loss; oral off-label but increasingly prescribed
13 Apr 2026
Antioxidant with cognitive enhancement potential, serotonin syndrome risk critical
13 Apr 2026
Bug report, content request, or general comment — we read everything.